Bedside-to-bench, not bench-to-bedside, is the best approach so far in neuropathic pain research

Lesen Sie diesen Artikel auf Deutsch.

The traditional bench-to-bedside approach of translational research has yielded only one approved therapy for neuropathic pain, so far. However, multimodal approaches offer hope for the future, explained Professor Nadine Attal during her plenary lecture at NeuPSIG 2019.

Ology Medical Education is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by Ology Medical Education for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, Ology Medical Education recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of Ology Medical Education or the sponsor. Ology Medical Education assumes no liability for any material contained herein.